Within the last 20 years, we’ve seen the rise of a new class of drug - GLP-1 medications - which are intended for obesity and type 2 diabetes. Recent research, however, seems to suggest that some GLP-1 medications could be used to relieve symptoms of sleep apnea. 

To learn more about these potential benefits, and the relationship between weight loss, sleep and sleep apnea, we’ve invited Dr. Spencer Nadolsky. 

An obesity and lipid specialist focused on exercise and nutrition, Dr. Spencer co-hosts the podcast Docs Who Lift, and is founder and CEO of Vineyard, a virtual health clinic specializing in GLP-1 medicines and cardiometabolic health.

Vineyard: https://joinvineyard.com/vineyard